Anti Cancer Injection

Product Details:

Letroz Tablet helps treat breast cancer in post-menopausal women. It may be used alone or with other treatments, such as surgery or radiation. It can also be used in patients with advanced breast cancer to stop the tumor from spreading to other parts of the body.

Letroz Tablet can be taken with or without food. Take it in the dose and duration prescribed by the doctor to get the most benefit. The dose and frequency depend on what you are taking it for. Your doctor will decide how much you need to improve your symptoms. You should take this medicine for as long as it is prescribed.

The most common side effects of this medicine include hot flashes, fatigue, increased sweating, and increased level of cholesterol (hypercholesterolemia). If these bother you or appear serious, let your doctor know. Your doctor may suggest ways to prevent or reduce these.

Before taking this medicine, tell your doctor if you have ever had liver or kidney disease, or have a history of osteoporosis (thinning or wasting of bones). Your doctor should also know about all other medicines you are taking as many of these may make this medicine less effective or change the way it works. Tell your doctor if you are pregnant or breastfeeding. Your doctor may perform some blood tests to check for vitamin D level or bone density before and during treatment.

Product Details:

Maruti Agency is one of the known trader for Anti Cancer medicine, injectable and mouth wash, Ahmedabad, Gujarat.                  

Product Details:

Trastuzumab 440 mg Injection is a targeted anticancer therapy used in the treatment of HER2-positive breast cancer and gastric cancer. It is a monoclonal antibody that specifically targets the human epidermal growth factor receptor 2 (HER2) on cancer cells.

Key Features

• Active Ingredient: Trastuzumab

• Strength: 440 mg

• Dosage Form: Powder for injection (to be reconstituted for IV infusion)

• Drug Class: Monoclonal antibody (HER2-targeted therapy)

• Route of Administration: Intravenous

Indications

• HER2-positive breast cancer (early-stage and metastatic)

• **HER2-positive metastatic gastric or gastroesophageal junction adenocarcinoma

• Used as monotherapy or in combination with chemotherapy as prescribed

Mechanism of Action

Trastuzumab binds to HER2 receptors on the surface of cancer cells, inhibiting cell proliferation and promoting antibody-dependent cellular cytotoxicity (ADCC), which helps the immune system destroy tumor cells.

Benefits

• Targeted therapy with selective action on HER2-positive tumors

• Can improve survival and reduce tumor progression

• Often used in combination with chemotherapy for enhanced efficacy

Dosage & Administration

• Administered via intravenous infusion under strict medical supervision

• Initial loading dose followed by maintenance doses every 1–3 weeks depending on treatment protocol

• Infusion reactions are possible, so patients should be monitored during administration

Storage

• Store refrigerated at 2–8°C

• Protect from light

• Do not freeze

• Use reconstituted solution as per guidelines

Safety Information

• Common side effects: fever, chills, headache, nausea, infusion-related reactions

• Serious risks: cardiotoxicity (especially in combination with anthracyclines), severe infusion reactions

• Regular cardiac monitoring is recommended during therapy

Additional Information:

• Item Code: Canmab

Product Details:

Lenalidomide 10 mg Capsule is an oral immunomodulatory and anticancer agent used primarily for blood cancers.

Key Features:

• Active Ingredient: Lenalidomide

• Strength: 10 mg

• Dosage Form: Capsule

• Drug Class: Immunomodulatory agent (IMiD)

• Route: Oral

Indications:

• Multiple myeloma (alone or with other therapies)

• Myelodysplastic syndromes (MDS) with deletion 5q

• Certain lymphomas as prescribed

Mechanism of Action:
Enhances immune response, inhibits abnormal blood vessel growth, and induces cancer cell apoptosis.

Benefits:

• Oral administration for convenience

• Improves disease control in hematologic malignancies

Safety Information:

• Side effects: fatigue, low blood counts, rash, constipation

• Highly teratogenic – strict pregnancy prevention required

• Regular blood monitoring is essential

Fosaprepitant Dimeglumine Injection

Fosaprepitant Dimeglumine Injection is an antiemetic used to prevent nausea and vomiting caused by chemotherapy.

Key Features:

• Active Ingredient: Fosaprepitant Dimeglumine

• Dosage Form: Injection (IV)

• Drug Class: NK1 receptor antagonist

• Route: Intravenous

Indications:

• Prevention of acute and delayed chemotherapy-induced nausea and vomiting (CINV)

Mechanism of Action:
Blocks neurokinin-1 (NK1) receptors in the brain, reducing the vomiting reflex.

Benefits:

• Single IV dose covers 24–48 hours post-chemotherapy

• Often used with 5-HT3 antagonists and corticosteroids for optimal effect

Safety Information:

• Side effects: fatigue, headache, constipation, hiccups

• Use with caution in patients with liver disease or certain drug interactions

                        

Additional Information:

• Item Code: Celdach50

Product Details:

Doxorubicin Injection IP is a potent anticancer (antineoplastic) medication widely used in chemotherapy for the treatment of various cancers. It belongs to the anthracycline antibiotic class and works by inhibiting cancer cell growth and division.

Key Features

• Active Ingredient: Doxorubicin Hydrochloride

• Pharmacopoeial Standard: IP (Indian Pharmacopoeia)

• Drug Class: Anthracycline antineoplastic agent

• Dosage Form: Sterile solution for injection

• Route of Administration: Intravenous use only

Indications

• Breast cancer

• Leukemias (acute lymphoblastic and acute myeloblastic leukemia)

• Lymphomas (Hodgkin’s and non-Hodgkin’s)

• Ovarian, bladder, lung, thyroid, and gastric cancers

• Soft tissue and bone sarcomas

Mechanism of Action

Doxorubicin intercalates into DNA, inhibiting topoisomerase II and preventing DNA replication and RNA synthesis. It also generates free radicals, leading to cancer cell death.

Benefits

• Broad-spectrum anticancer activity

• Effective as monotherapy or in combination chemotherapy regimens

• Long-standing, clinically proven efficacy

Administration & Handling

• Administered strictly by slow intravenous injection or infusion

• Extravasation can cause severe tissue damage; careful handling is required

• Cumulative dose monitoring is essential due to cardiotoxicity risk

Storage

• Store below 25°C

• Protect from light

• Do not freeze

Safety Information

• Common side effects include nausea, vomiting, hair loss, mouth sores, and bone marrow suppression

• Serious risk of cardiotoxicity with high cumulative doses

• Use only under strict medical supervision by an oncologist

Additional Information:

• Item Code: Doxoruba10mg